Technical Data
B2553-33H
Bone Morphogenetic Protein 7 (BMP7, OP-1, Osteogenic Protein-1) (Biotin)
Description:
Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
Direct, Sandwich ELISA: 0.25-1ug/ml (using 100ul/well antibody solution).Used in conjunction with compatible secondary reagents, allows the detection of at least 0.2-0.4ng/well of recombinant hBMP-7/OP-1.

Western Blot: 0.1-0.2ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant hBMP-7/OP-1 is 1.5-3.0ng/lane, under either reducing or non-reducing conditions.
Optimal dilutions to be determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Reconstitute to nominal volume by adding sterile 40-50% glycerol, PBS, 0.1% BSA. Aliquot and store at -20C. Reconstituted product is stable for 6 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

Country of Origin:
USA
TypeIsotypeCloneGrade
PabIgGAffinity Purified
SizeStorageShippingSourceHost
25ug4C (-20C Glycerol)Blue IceHumanRabbit
Concentration:
Not Detremined
Immunogen:
Highly pure (> 98%) recombinant human BMP-7/OP-1.
Purity:
Purified by immunoaffinity chromatography.
Form
Supplied as a lyophilized powder from PBS, pH 7.2. Labeled with Biotin. Reconstitute with sterile 40-50% glycerol, PBS, 0.1% BSA to 0.1-1mg/ml.
Specificity:
Recognizes human BMP-7.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.